Journal
BRITISH JOURNAL OF CANCER
Volume 125, Issue 2, Pages 149-151Publisher
SPRINGERNATURE
DOI: 10.1038/s41416-021-01315-y
Keywords
-
Categories
Ask authors/readers for more resources
Inhibiting the chemokine receptor CXCR4 suppresses intratumoral immune reaction, providing insights into the role of CXCR4 in cancer immunoediting.
A recent Phase 1 clinical study of the immunological effects of inhibiting the chemokine receptor, CXCR4, in patients with pancreatic ductal adenocarcinoma or colorectal cancer suggests that stimulation of CXCR4 on immune cells suppresses the intratumoural immune reaction. Here, we discuss how CXCR4 mediates this response, and how cancer cells elicit it.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available